As new session begins, Lt. Gov. Patrick calling for lawmakers to pass the Dementia Prevention Research Institute and offer ...

Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these ...

Nearly 7 million Americans have been diagnosed with dementia, which slowly erodes memory, thinking skills and the ability to ...

Researchers have discovered that suppressing a nucleolar complex can reduce Alzheimer’s-related protein toxicity. Scientists ...

Discover how dopamine’s unexpected role in breaking down harmful plaques could revolutionize Alzheimer's treatment and ...

A clinical trial in Chinese public hospitals is showing promise, but experts stress that further studies are needed.

Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...

SALT LAKE CITY — After years of stagnation in the search for a cure for Alzheimer's — or at least breakthroughs — 2024 brought several exciting findings and confirmed others regarding the ...

FDA sets August 31, 2025, as the action date for Eisai and Biogen's Leqembi subcutaneous autoinjector application. Leqembi's ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...